New Jersey Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Jersey Health Reporter.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on March 5, 2026

Mar. 5, 2026

AST Announces IP3 2025 Results: 47 Patent Transactions and $5.1M Invested in Collaborative Patent Defense

EIN Presswire

Mar. 5, 2026

NJ Top Dentists Approves Dr. Navneet Rai Based on Merit For 2025

EIN Presswire

Mar. 5, 2026

2026 NJ Top Docs Honors Hunterdon Hematology Oncology Team

EIN Presswire

Mar. 5, 2026

MediDepot Launches Request-a-Quote System to Simplify Medical Equipment Procurement

EIN Presswire

Mar. 5, 2026

Calidi Biotherapeutics Announces Proposed Public Offering

GlobeNewswire

Mar. 5, 2026

President & CEO Letter to Shareholders

GlobeNewswire

Mar. 5, 2026

Nova Leap Health Corp. Posts Fourth Quarter and Record Full-Year 2025 Revenues and Adjusted EBITDA

GlobeNewswire

Mar. 5, 2026

COSCIENS Provides Strategic Update

GlobeNewswire

Mar. 5, 2026

MediWound Files Annual Report on Form 20-F

GlobeNewswire

Mar. 5, 2026

MannKind Announces Settlement of Convertible Senior Notes

GlobeNewswire

Mar. 5, 2026

New Book “Avoiding Toxins” Offers a Physician’s Practical Playbook for Navigating America’s Hidden Environmental Exposure Crisis

GlobeNewswire

Mar. 5, 2026

Kyverna Therapeutics to Present New Data from Neuroimmunology Franchise at AAN 2026

GlobeNewswire

Mar. 5, 2026

CooperCompanies Announces First Quarter 2026 Results

GlobeNewswire

Mar. 5, 2026

Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development

GlobeNewswire

Mar. 5, 2026

Outlook Therapeutics Provides Update Following Type A Meeting with FDA Regarding ONS-5010/LYTENAVA™ (bevacizumab-vikg)

GlobeNewswire

Mar. 5, 2026

Omada Health Announces GLP-1 Flex Care, Giving Employers a New, Flexible Path to Support Obesity Care

GlobeNewswire

Mar. 5, 2026

Nyxoah Publiera ses Résultats Financiers du Quatrième Trimestre et de l’Année 2025 le 19 Mars 2026

GlobeNewswire

Mar. 5, 2026

Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

GlobeNewswire

Mar. 5, 2026

CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights

GlobeNewswire

Mar. 5, 2026

Regeneron Announces Investor Conference Presentation

GlobeNewswire